Organization
Jamp Pharma Corporation
1 clinical trial
Clinical trial
The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.Status: Recruiting, Estimated PCD: 2024-09-18